An easily measured gene has been linked to high mortality rate in patients with Pseudomonasaeruginosa bloodstream infections, and could be used as a prognostic biomarker and potential treatment target in these individuals, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID; 21–24 April, Madrid, Spain).
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.
